March 6, 2014: Boston Heart launches MPO as part of its inflammation test offerings. Get started today with inflammation testing.
Our Exclusive Tests
Boston Heart Diagnostics is helping to fulfill the promise of personalized medicine. We are committed to adding to our exclusive portfolio and suite of cardiovascular disease (CVD)-focused tests that are designed to improve outcomes for patients and save health dollars by tailoring a therapeutic regimen to the patient’s particular circumstances.
Our Test Menu
Visit our test menu to learn more about Boston Heart’s comprehensive test portfolio, including test description, methodology, specimen requirements, lab values, clinical significance, and treatment options.
Forbes lists Boston Heart within the top 100 privately held, high-growth companies with bright futures
Boston Heart ranks number eight fastest growing company in North America on Deloitte’s 2013 Technology Fast 500™
Ernst & Young Entrepreneur Of The Year® 2013 names Boston Heart CEO as New England finalist